- For Researchers
- For Biospecimen Contributors
- For Patients
- Human Biospecimens
The iSpecimen Marketplace transforms the process of acquiring and contributing human biospecimens for research. Powered by proprietary technology, our vast network of qualified biospecimen partners offers instant access to millions of richly characterized specimens.
of researchers limit research due to lack of biospecimens
of biorepositories report sustainability is a concern
of biospecimens available in the iSpecimen Marketplace
“The iSpecimen Marketplace allows us to reach thousands of scientists.”
Amer Abouhamze, MHA, Assistant Director, CTSI Biorepository, University of Florida
“iSpecimen enabled us to immediately expand our sourcing of tumor types that we did not have a channel for.”
David Deems, President, Cellaria
“This process previously required a lot of paperwork and time. iSpecimen makes it so much easier and quicker.”
LeeAnn Talarico, Prinicipal Investigator, SQZ Biotech
“Our partnership with iSpecimen allows us to expand our reach across the scientific community, providing specimens directly for the discovery of new diagnostics and therapeutics.”
Eric Carbonneau, MS, MT (ASCP), Director of Core Lab Operations & Research Institute, TriCore Solutions
A majority of global biobanks – collectors of human fluids, cells and tissue for biomedical research – are underutilizing their specimens while struggling with financial pressures that threaten their long-term viability, suggests a new review of biobanks and biorepositories conducted by iSpecimen. Read more.
iSpecimen today announced it has established a panel of respected partners and industry experts to counsel the company in its mission of supplying biomedical researchers with the specimens they need from the patients who have them. Read more.
Siemens Healthineers and iSpecimen announced they will aid laboratories in generating new sources of revenue through the integration of Siemens Healthineers’ laboratory automation systems with iSpecimen’s biospecimen marketplace. Read more.